Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (71-80 of 1,235) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|December 20, 2018
On weighted composite scores for early Alzheimer's trialsKun Jin, Briana Cameron, Billy Dunn
Pharmaceutical Statistics|November 22, 2019
Two-stage phase II survival trial designJianrong Wu, Li Chen, Jing Wei, et al.
Pharmaceutical Statistics|October 31, 2019
Nonlinear mixed-effects models with misspecified random-effects distributionReza Drikvandi
Pharmaceutical Statistics|January 18, 2019
Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptationsSilke Jörgens, Gernot Wassmer, Franz König, et al.
Pharmaceutical Statistics|January 18, 2019
Blinded sample size reestimation in event-driven clinical trials: Methods and an application in multiple sclerosisTim Friede, Harald Pohlmann, Heinz Schmidli
Pharmaceutical Statistics|January 31, 2019
Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disordersDeli Wang, Weining Robieson, Jun Zhao, et al.
Pharmaceutical Statistics|December 31, 2019
A flexible multi-domain test with adaptive weights and its application to clinical trialsYang Zhao, Qifeng Yu, Stephen L Lake
Pharmaceutical Statistics|December 13, 2019
Testing treatment-by-period interaction in four-period crossover trialsBo Li, Zaiying Zhou, Li Zhang, et al.
Pharmaceutical Statistics|December 13, 2019
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomesKentaro Takeda, Satoshi Morita, Masataka Taguri
Pharmaceutical Statistics|February 24, 2018
Bayesian approach for assessing noninferiority in a three-arm trial with binary endpointSantu Ghosh, Ram C Tiwari, Samiran Ghosh
Pageof 124

Showing results (71-80 of 1,235) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|December 20, 2018
On weighted composite scores for early Alzheimer's trialsKun Jin, Briana Cameron, Billy Dunn
Pharmaceutical Statistics|November 22, 2019
Two-stage phase II survival trial designJianrong Wu, Li Chen, Jing Wei, et al.
Pharmaceutical Statistics|October 31, 2019
Nonlinear mixed-effects models with misspecified random-effects distributionReza Drikvandi
Pharmaceutical Statistics|January 18, 2019
Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptationsSilke Jörgens, Gernot Wassmer, Franz König, et al.
Pharmaceutical Statistics|January 18, 2019
Blinded sample size reestimation in event-driven clinical trials: Methods and an application in multiple sclerosisTim Friede, Harald Pohlmann, Heinz Schmidli
Pharmaceutical Statistics|January 31, 2019
Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disordersDeli Wang, Weining Robieson, Jun Zhao, et al.
Pharmaceutical Statistics|December 31, 2019
A flexible multi-domain test with adaptive weights and its application to clinical trialsYang Zhao, Qifeng Yu, Stephen L Lake
Pharmaceutical Statistics|December 13, 2019
Testing treatment-by-period interaction in four-period crossover trialsBo Li, Zaiying Zhou, Li Zhang, et al.
Pharmaceutical Statistics|December 13, 2019
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomesKentaro Takeda, Satoshi Morita, Masataka Taguri
Pharmaceutical Statistics|February 24, 2018
Bayesian approach for assessing noninferiority in a three-arm trial with binary endpointSantu Ghosh, Ram C Tiwari, Samiran Ghosh
Pageof 124